As many as two million women in the U.S. use customized hormones for menopause symptoms. T.S. Wiley is the developer of the Wiley Protocol, a patent pending delivery system consisting of bio-mimedic estradiol and progesterone in topical cream preparations. Wiley has pioneered the standardization of the formulation using a unique compounding procedure and color coded packaging all available to physicians and women at a recommended retail price. In order to fill a physician's prescription for the Wiley Protocol, pharmacists must be registered by Wiley Systems™, Inc. in a licensing agreement.

T.S. Wiley began with a project to unite doctors and pharmacists in a common goal to standardize bio-identical hormones for academic research. Wiley Systems offers the packaging to color code and accurately titrate dosing for the Wiley Protocol to pharmacies who join the project for future NIH study.

Registration for pharmacists means, in essence, a trade for the right to use the name Wiley Protocol for the product produced when a physician calls in a prescription for the Wiley Protocol, in exchange for a contract that specifies the methods, materials, packaging and recommended pricing of the Wiley Protocol at their individual pharmacies. These requirements of good compounding (manufacturing) practices apply only to the production and compounding of the Wiley Protocol.

Wiley Systems, Inc. has pioneered the standardization of the formulation using a unique compounding procedure and color coded packaging all available to physicians and women at a recommended retail price. The hormone levels in serum blood work mimic those produced by a twenty year-old woman.

"Natural hormones are not bio-mimedic unless the body can recognize them as hormones, and they are not considered restoration unless what has been lost is truly restored," said T.S. Wiley, founder of the Wiley Protocol and Wiley Systems, Inc. "I wondered if hormone restoration was made of real bio-mimedic hormones and dosed to mimic the ups and downs of the hormone blood levels in a normal menstrual cycle in a 20 year-old woman, would all of the symptoms and disease states of aging decline or even, disappear?"

Wiley Systems has created the registered pharmacy system to circumvent the current lack of legitimacy and availability of bio-identical hormones for testing and study. By standardizing the compounds in the Wiley Protocol and registering enough pharmacies, the Wiley Protocol can then be donated (a minuscule percent of total sales volume contractually per pharmacy) and studied by the IRB at University of Texas in a standard acceptable to the National Institute of Health (NIH), which dictates that a study substance must be donated.

About Wiley Systems™:
Wiley Systems, Inc. was founded in 2005 in Santa Barbara, California. T.S. Wiley is the developer of The Wiley Protocol®, a trademarked patent pending delivery system consisting of bio-mimetic estradiol and progesterone in topical cream preparations dosed in a rhythmic cycle. The hormone levels in serum blood work mimic those produced by a twenty year-old woman. The Wiley Protocol is the only hormone restoration therapy (BHRT) that has used natural hormones in a bio-mimetic way or that has ever been developed under the scrutiny of a practicing oncologist.

Wiley Systems began as a project to unite doctors and pharmacists in a common goal to standardize bio-identical hormones for academic research. Wiley Systems offers the packaging to color code and accurately titrate dosing for the Wiley Protocol to pharmacies who join the project for future NIH study.

The authentic Wiley Protocol is only available at compounding pharmacies that have agreed to the standardized methods, materials, packaging and recommended pricing. In exchange, Wiley Systems provides intellectual property and sells pre-stamped 28WP logo-bearing packaging consisting of bags, labels and syringes in the branded colors of purple and green. The Wiley Protocol name assures customers that they are receiving the authentic Wiley Protocol.